U.S. markets closed

Outlook Therapeutics, Inc. (OTLK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4200-0.0600 (-2.42%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/24/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
420.13M390.61M165.34M91.57M163.00M
Enterprise Value 3
394.33M396.33M165.34M76.47M176.83M
Trailing P/E
40.33N/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
13.27N/AN/A6.056.47
Price/Book (mrq)
20.34N/A58.508.35N/A
Enterprise Value/Revenue 3
23.71N/AN/AN/AN/A
Enterprise Value/EBITDA 7
-9.27-31.03-11.63-7.78-30.91

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 375.89%
S&P500 52-Week Change 334.82%
52 Week High 34.2600
52 Week Low 30.5800
50-Day Moving Average 32.4897
200-Day Moving Average 32.1622

Share Statistics

Avg Vol (3 month) 3939.56k
Avg Vol (10 day) 3611.11k
Shares Outstanding 5173.61M
Implied Shares Outstanding 6N/A
Float 88.62M
% Held by Insiders 148.37%
% Held by Institutions 19.02%
Shares Short (Jun 29, 2021) 44.21M
Short Ratio (Jun 29, 2021) 43.37
Short % of Float (Jun 29, 2021) 44.15%
Short % of Shares Outstanding (Jun 29, 2021) 42.43%
Shares Short (prior month May 27, 2021) 41.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 17, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Mar 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-104.25%
Return on Equity (ttm)-64,034.97%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-26.34M
EBITDA -48.24M
Net Income Avi to Common (ttm)-40.5M
Diluted EPS (ttm)-0.3340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.17M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)11.37M
Total Debt/Equity (mrq)55.06
Current Ratio (mrq)1.83
Book Value Per Share (mrq)0.12

Cash Flow Statement

Operating Cash Flow (ttm)-43.1M
Levered Free Cash Flow (ttm)-27.86M